Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baohong Yang

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Surgery|April 3, 2026
Editorial: Novel techniques for colorectal cancerMauro Podda, Baohong Yang
International Reviews of Immunology|May 17, 2012
Amino acid metabolism related to immune tolerance by MDSCsBaohong Yang, Xiaomeng Wang, Xiubao Ren
Frontiers in Oncology|July 19, 2021
Case Report: Squamous Cell Carcinoma of Pancreas With High PD-L1 Expression: A Rare PresentationBaohong Yang, Haipeng Ren, Guohua Yu
Gene|August 28, 2012
Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studiesYang Wang, Baohong Yang, Xiubao Ren
Oncotargets and Therapy|January 11, 2018
The RNASEL -1385G/A polymorphism is associated with risk of prostate cancer in AfricansXiaolei Liu, Dejie Zheng, Guowei Lu, et al.
Archives of Dermatological Research|August 16, 2012
Association between TERT-CLPTM1L rs401681[C] allele and NMSC cancer risk: a meta-analysis including 45,184 subjectsXueling Yang, Baohong Yang, Bo Li, et al.
Indian Journal of Dermatology|June 1, 2013
The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjectsXueling Yang, Baohong Yang, Ya Liu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 26, 2018
Circulating tumor cells predict prognosis following secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell lung cancer patientsBaohong Yang, Dejie Zheng, Υanyan Zeng, et al.
Oncology Research|May 6, 2017
Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer PatientsBaohong Yang, Aiying Qin, Kongyuan Zhang, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysisShuzhen Liu, Yongchun Cui, Baohong Yang, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Surgery|April 3, 2026
Editorial: Novel techniques for colorectal cancerMauro Podda, Baohong Yang
International Reviews of Immunology|May 17, 2012
Amino acid metabolism related to immune tolerance by MDSCsBaohong Yang, Xiaomeng Wang, Xiubao Ren
Frontiers in Oncology|July 19, 2021
Case Report: Squamous Cell Carcinoma of Pancreas With High PD-L1 Expression: A Rare PresentationBaohong Yang, Haipeng Ren, Guohua Yu
Gene|August 28, 2012
Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studiesYang Wang, Baohong Yang, Xiubao Ren
Oncotargets and Therapy|January 11, 2018
The RNASEL -1385G/A polymorphism is associated with risk of prostate cancer in AfricansXiaolei Liu, Dejie Zheng, Guowei Lu, et al.
Archives of Dermatological Research|August 16, 2012
Association between TERT-CLPTM1L rs401681[C] allele and NMSC cancer risk: a meta-analysis including 45,184 subjectsXueling Yang, Baohong Yang, Bo Li, et al.
Indian Journal of Dermatology|June 1, 2013
The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjectsXueling Yang, Baohong Yang, Ya Liu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 26, 2018
Circulating tumor cells predict prognosis following secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell lung cancer patientsBaohong Yang, Dejie Zheng, Υanyan Zeng, et al.
Oncology Research|May 6, 2017
Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer PatientsBaohong Yang, Aiying Qin, Kongyuan Zhang, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysisShuzhen Liu, Yongchun Cui, Baohong Yang, et al.
Pageof 2